Director Shareholding

GlaxoSmithKline PLC 10 September 2004 Directors' Interests I give below details of changes in directors' interests in the Ordinary Shares of GlaxoSmithKline plc. 8 September 2004 Abacus (GSK) Trustees Limited, as trustee of the GlaxoSmithKline Employee Trust, ("the GSK Trust"), transferred 1,128 Ordinary Shares in the Company to a participant in the SmithKline Beecham Mid Term Incentive Plan. 8 September 2004 Abacus (GSK) Trustees Limited, as trustee of the GSK Trust, sold 784 Ordinary Shares in the Company on behalf of a participant in the SmithKline Beecham Mid Term Incentive Plan at a price of £11.41099 per Ordinary share. The Company was advised of these transactions on 10 September 2004. The GSK Trust is a discretionary trust of which all employees or former employees of GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. Three of the Company's directors, Dr J-P Garnier, Dr T Yamada and Mr J D Coombe are therefore interested in the shares held in the GSK Trust from time to time in the same way as other employees or former employees of GlaxoSmithKline plc and its subsidiaries. S M Bicknell Company Secretary 10 September 2004 This information is provided by RNS The company news service from the London Stock Exchange

Companies

GSK (GSK)
UK 100

Latest directors dealings